Life Science REIT PLC (LABS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Life Science REIT PLC (LABS) has a cash flow conversion efficiency ratio of 0.004x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX958.00K ≈ $116.56 USD) by net assets (GBX233.06 Million ≈ $28.36K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Life Science REIT PLC - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Life Science REIT PLC carry for a breakdown of total debt and financial obligations.
Life Science REIT PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Life Science REIT PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rainbow Polikarbonat Sanayi Ticaret AS
IS:RNPOL
|
0.103x |
|
Bridge Saas Ltd
AU:BGE
|
0.026x |
|
ProAm Explorations Corp
V:PMX
|
0.370x |
|
Fintech Chain Ltd
AU:FTC
|
-0.019x |
|
Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC
LSE:MCT
|
0.005x |
|
Monarca Minerals Inc
V:MMN
|
0.008x |
|
Alexium International Group Limited
F:E7T
|
-0.087x |
|
Regional REIT Ltd
LSE:RGL
|
0.014x |
Annual Cash Flow Conversion Efficiency for Life Science REIT PLC (2021–2024)
The table below shows the annual cash flow conversion efficiency of Life Science REIT PLC from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see Life Science REIT PLC stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX262.77 Million ≈ $31.97K |
GBX12.92 Million ≈ $1.57K |
0.049x | +83.22% |
| 2023-12-31 | GBX283.75 Million ≈ $34.52K |
GBX7.62 Million ≈ $926.53 |
0.027x | +887.98% |
| 2022-12-31 | GBX319.45 Million ≈ $38.87K |
GBX-1.09 Million ≈ $-132.38 |
-0.003x | -133.75% |
| 2021-12-31 | GBX350.58 Million ≈ $42.66K |
GBX3.54 Million ≈ $430.47 |
0.010x | -- |
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.